Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
The Risk of the Next Child Getting Affected by Chronic Granulomatous Disease in Families With at Least One Autosomal Recessive Cgd Child Publisher Pubmed



Modarresi SZ1, 2 ; Tajik S1 ; Badalzadeh M1 ; Fazlollahi MR1 ; Houshmand M3 ; Maddah M1 ; Alizadeh Z1 ; Nabavi M4 ; Bazargan N5 ; Movahedi M1, 6 ; Pourpak Z1
Authors

Source: Iranian Journal of Allergy# Asthma and Immunology Published:2023


Abstract

Chronic granulomatous disease (CGD) is a rare primary immunodeficiency disorder more common in autosomal recessive (AR) than X-linked in Iran. This study aimed to assess whether having a child with AR-CGD would increase the likelihood of the next child being affected by CGD. Ninety-one families with at least one child affected by AR-CGD entered this study. Out of the 270 children, 128 were affected by AR-CGD. We used a cross tab for the odds ratio (OR) calculation, in which exposure to a previously affected child and the next child’s status were evaluated. This study illustrated that the chances of having another child afflicted with AR-CGD are significantly increased if the previous child had AR-CGD (OR=2.77, 95% CI=1.35-5.69). Although AR disorders affect 25% of each pregnancy, we showed that the chance that the next child would be affected by CGD, given that the previous child was affected, is 2.77 times greater than in families with a normal child. It is recommended to warn families with one or more affected children to evaluate the risk of CGD in their subsequent pregnancies with prenatal diagnosis. Copyright © 2023 Modarresi et al. Published by Tehran University of Medical Sciences.
Other Related Docs
4. Primary Immunodeficiency Diseases in Northern Iran, Allergologia et Immunopathologia (2017)
9. A Novel Cybb Mutation in Chronic Granulomatous Disease in Iran, Iranian Journal of Allergy# Asthma and Immunology (2016)
18. Immunological Evaluation of Pediatric Patients With Polyautoimmunity, Endocrine# Metabolic and Immune Disorders - Drug Targets (2024)